Ipratropium bromide, Levosalbutamol

-Ipratropium Bromide is an anticholinergic bronchodilator that works by relaxing muscles in the airways and increasing airflow to the lungs. -Levosalbutamol is a bronchodilator that relaxes muscles in the airways and increases airflow to the lungs.

Indications

Treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) and asthma.

Dosage

-The usual dose for adults is 1 inhalation (20 mcg ipratropium bromide/50 mcg levosalbutamol) four times a day. -Dosage may vary based on individual patient response and severity of the condition.

Contra-Indications

-Hypersensitivity to ipratropium bromide, levosalbutamol, or any components of the formulation. -Patients with a history of allergic reactions to atropine or its derivatives.

Special Precautions

-Use with caution in patients with narrow-angle glaucoma, prostatic hypertrophy, bladder neck obstruction, or urinary retention. -Not intended for the initial treatment of acute episodes of bronchospasm. -Patients should be advised to seek medical attention if symptoms worsen or do not improve with use. -Use with caution in patients with cardiovascular disorders, including arrhythmias and hypertension.

Side Effects

-Common side effects may include dry mouth, headache, dizziness, cough, or throat irritation. -Serious side effects such as palpitations, urinary retention, blurred vision, or allergic reactions may occur rarely.

Drug Interactions

-Concomitant use with other anticholinergic medications may increase the risk of side effects. -Beta-blockers may antagonize the effects of levosalbutamol.